Thalidomide therapy for cicatricial pemphigoid

被引:13
|
作者
Duong, DHJ
Moxley, RT
Kellman, RM
Pincus, SH
Gaspari, AA [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Dermatol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Microbiol Immunol, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Ctr Canc, Rochester, NY 14642 USA
[4] SUNY Syracuse, Dept Neurol, Syracuse, NY USA
[5] SUNY Syracuse, Dept Otolaryngol, Syracuse, NY USA
[6] SUNY Buffalo, Dept Dermatol, Buffalo, NY 14260 USA
关键词
D O I
10.1067/mjd.2002.109255
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cicatrical pemphigoid is a chronic, presumed autoimmune, blidtering disease of the mucous membranes and occasionally of the skin. The characteristic feature of scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant desease.
引用
收藏
页码:S193 / S195
页数:3
相关论文
共 50 条